 Buy trial packs

Hello,
Just received my order tonight. Once again, I thank you for your help – as well as the great products! You have showed an exceptional professionalism and
I look forward to doing more business with you.
- Carlos E.,
Staten Island, United States
|

News: India
Category:
Drug Prices
Region:
India
|
|
INDIA TO SEEK GREATER MARKET ACCESS FOR DOMESTIC GENERIC DRUGS IN JAPAN
Date: 28-Dec-2011
Author: ET Bureau
|
|
Category:
Drug Prices
Region:
India
|
|
INDIAN CONSUMERS WILL BE ABLE TO CHOOSE THE CHEAPEST MEDICINE FROM A LIST OF ALTERNATIVES, THROUGH AN SMS.
Date: 29-Nov-2011
Author: Nirmal Bang
To make the prices of medicines cheaper and affordable to commoners, the government, through the National Pharmaceutical Pricing Authority (NPPA), some time back proposed to launch a new initiative, which is a technology-advanced programme enabling them to choose the cheapest brand of drug prescribed by doctors.
|
|
Category:
Drug Prices
Region:
India
|
|
LOCOST: AFFORDABLE DRUGS FOR EVERYONE
Date: 6-Nov-2011
Author: Durga Chandran
Low Cost Standard Therapeutics, or LOCOST, was set up to enable everyone, even the poor in remote areas, to access quality medicines at affordable prices.
|
|
Category:
Health/Science
Region:
India
|
|
REPORT ON INDIA'S PHARMACEUTICAL INDUSTRY
Date: 7-Oct-2011
Author: Anshu Shrivastava
The Indian pharmaceutical industry in recent years has grown in stature from an industry that copies patent drugs and manufactures them cheaply. It's now counted among the industries that are fueling India's economic growth and holds vast potential. India-based pharmaceutical companies are also predicted to gain considerable market share in the world by the end of this decade. The industry is estimated to have generated revenue worth US$13.1 billion in FY 2011, according to a new Research and Market's report, "Indian Pharma Sector Forecast 2014."
|
|
Category:
Health/Science
Region:
India
|
|
INDIA PATENT CASE THREATENS CHEAP DRUG SUPPLY
Date: 5-Sep-2011
Author: AGENCE FRANCE PRESSE
Supply of cheap copycat drugs for the developing world could be blocked if Swiss pharmaceutical giant Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
|
|
|
Next page >>
|
|


|
|
About us | F.A.Q. | How to Order | Contact us | RX online | Drugs directory
Copyright © 2006 - 2012 DRUGSWWW.com All rights reserved.
|
|